Quick answer
Avoid counterfeits
What Mounjaro is & how it works
Mounjaro's active ingredient is tirzepatide. Unlike the semaglutide drugs, it activates two gut-hormone receptors — GIP as well as GLP-1 — which appears to amplify appetite reduction and metabolic effects. That dual action is why it tends to outperform semaglutide on weight loss.
In South Africa, Mounjaro is registered for type 2 diabetes, and a chronic weight-management indication was granted in late 2025. It's supplied as single-dose pens or vials, taken once a week. Compare it directly in Ozempic vs Mounjaro and Wegovy vs Mounjaro.
Who it's for
Mounjaro is generally considered for adults with a BMI of 30 or more, or 27 or more with a weight-related condition (such as type 2 diabetes, high blood pressure or sleep apnoea), as part of a wider plan that includes diet and activity. It isn't suitable for everyone — for example in pregnancy, or with certain personal/family histories of medullary thyroid cancer or MEN 2.
Eligibility is a clinical decision. Check the thresholds in am I eligible? or try the private BMI calculator. Book a consultation with a registered provider
Realistic results
Tirzepatide's weight-loss evidence comes from the SURMOUNT trials. In SURMOUNT-1, adults without diabetes lost up to about 21–22.5% of body weight on average at the highest dose over 72 weeks — the largest figures seen for a weight-loss medicine. In the head-to-head SURMOUNT-5 trial, tirzepatide beat semaglutide (~20.2% vs 13.7%).
As always, these are averages alongside diet and lifestyle changes; individual results vary and we don't publish guarantees.
Side effects & safety
The most common side effects of Mounjaro are gastrointestinal — nausea, constipation, diarrhoea and reflux — usually worst at the start or after a dose increase, and easing over time. Slow titration and simple diet adjustments help a lot.
Less common but serious risks include pancreatitis and gallbladder problems. Our full side effects & management guide explains what to expect and when to seek help.
When to seek help
Mounjaro price in South Africa
Roughly 4 vials/pens a month at maintenance. SA's best-selling pharma product. Prices vary between Dis-Chem, Clicks and Medirite, and change often.
| Medicine | Dose | Typical / month | Note |
|---|---|---|---|
| MounjaroTirzepatide | 2.5 / 5 mg | R3,500 – R3,900 | Roughly R880–R1,000 per vial/pen, ~4 a month. |
| MounjaroTirzepatide | 7.5 / 10 mg | R4,200 – R4,600 | Maintenance range. |
| MounjaroTirzepatide | 12.5 / 15 mg | R4,600 – R5,200 | Highest doses; availability varies. |
Remember the hidden costs: the consultation (from ~R250 via telehealth), baseline and follow-up bloods, needles and cold-chain delivery. Your monthly cost also rises as the dose steps up.
Medical-aid cover
For weight loss, most South African schemes do not fund Mounjaro as a chronic benefit, because obesity isn't a Prescribed Minimum Benefit. Some plans allow payment from a medical savings account or day-to-day benefit. See the scheme-by-scheme breakdown in medical-aid cover.
How to get Mounjaro in South Africa
Mounjaro is a Schedule 4 medicine — you need a prescription from a registered doctor, and you should only get the medicine from a licensed pharmacy. The usual routes are an in-person GP or a reputable telehealth service (online scripts from around R250), with the medicine dispensed or couriered to you under cold chain. A provider will check your eligibility, start you on a low dose and titrate up.
Avoid anyone offering Mounjaro without a prescription or at prices that look too good — SAHPRA has warned about falsified semaglutide circulating in SA.
Next step